Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Ostarine and the Muscular System: Scientific Evidence

Ostarine, also known as MK-2866 or Enobosarm, is a selective androgen receptor modulator (SARM) developed to help treat muscle wasting conditions. Its primary mode of action involves binding to androgen receptors in muscle and bone tissue, resulting in increased protein synthesis and muscle growth without the androgenic side effects commonly associated with anabolic steroids.

Multiple clinical trials have investigated Ostarine’s efficacy in supporting muscle mass. For instance, a pivotal randomized, double-blind, placebo-controlled Phase II trial (Dalton et al., 2011) in elderly men and postmenopausal women demonstrated significant increases in lean body mass and physical function with Ostarine compared to placebo, with a favorable safety profile. Other studies have echoed these findings, showing that Ostarine can help prevent muscle wasting in cancer patients and other populations at risk of muscle loss.

Despite promising results, Ostarine is not approved for medical use by the FDA due to concerns about long-term safety and potential side effects. It is, however, banned by the World Anti-Doping Agency (WADA) because of its muscle-enhancing properties and misuse in athletic contexts.

In summary, there is robust scientific evidence supporting Ostarine’s role in increasing muscle mass and strength, particularly in populations at risk for muscle wasting. However, its use should be approached cautiously due to regulatory status and incomplete long-term safety data.

More about Ostarine
More about Muscles

Other ingredients that support Muscles

Other body systems supported by Ostarine

Products containing Ostarine